Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balloon + Oxytocin vs Oral Misoprostol for Labor Induction in PROM (RUBAPRO2)
NCT05568745Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jan 2023
- Primary completion
- Aug 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in premature rupture of membranes (PROM) comparing Balloon+oxytocin with Oral misoprostol (2 arms). Primary endpoints: Proportion of patients vaginally delivered <24h and Patient satisfaction using EXIT survey up to 4 days. Started Jan 2023; status: terminated.
02
Drugs
oxytocinmisoprostol
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT05568745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05568745.